US sales help Lupin boost Q2 net 46%

Driven by US market sales and finished drug exports, Lupin has posted a 46% jump in net profit at Rs 75.6 crore for the quarter ended September 2007 (Q2FY08) when compared with Rs 51.9 crore in Q2FY07.

Gross sales for the period grew by 35% to Rs 6,75.6 crore from Rs 4,99.5 crore during Q2FY07.

Total export revenues have risen 59% to Rs 329.9 crore. Of these, formulation exports to advanced markets (North America and Europe) constituted 48% at Rs 157 crore. Formulation revenues from domestic market were up 22% Rs 2,60.2 crore.

Total formulation revenues from North America and Europe grew 126% to Rs 1,57 crore for the period, said Lupin.